MedTrace Logo

The Effect of Emotional Freedom Techniques Application on Patients With Cancer Phobia

NCT06816576 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2026-01-05

No results posted yet for this study

Summary

The aim is to examine the effect of Emotional Freedom Technique on death anxiety in patients with postoperative cancer phobia.

The hypotheses of the study are as follows:

H0: Emotional Freedom Technique has no effect on postoperative death anxiety in patients with cancer phobia.

H1: Emotional Freedom Technique has a positive effect on postoperative death anxiety in patients with cancer phobia.

Conditions

  • Postoperative Complications
  • Emotion Regulation
  • Death Anxiety

Interventions

OTHER

Emotional Freedom Technique

Emotional Freedom Technique application; It is an application that works on cognitive and energetic levels. Emotional Freedom Technique Application Instructions 1. Determination of Subjective Units of Disturbance (SUD) 2. Preparation or setup 3. Application of appropriate acupuncture points in order 4. 9-Gamut: An application that allows the two hemispheres of the brain to be stimulated simultaneously 5. Application of appropriate acupuncture points in order again 6. Control of the differentiation in the level of discomfort with Subjective Units of Disturbance again

Sponsors & Collaborators

  • Bitlis Eren University

    lead OTHER

Principal Investigators

  • Şerafettin OKUTAN, Dr. · Bitlis Eren University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-10
Primary Completion
2025-09-28
Completion
2025-10-10

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06816576 on ClinicalTrials.gov